MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹8,300 Cr | ₹196 Cr | ₹163 Cr | ₹868 Cr | ₹235 Cr |
What is the latest Total Debt ratio of MANKIND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹8,300 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹868 Cr |
| Mar2021 | ₹235 Cr |
How is Total Debt of MANKIND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,300 Cr | 4,134.07 | |
| Mar2024 | ₹196 Cr | 20.54 | |
| Mar2023 | ₹163 Cr | -81.26 | |
| Mar2022 | ₹868 Cr | 270.12 | |
| Mar2021 | ₹235 Cr | - | |
Compare Total Debt of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹88,884.1 Cr | -3.5% | -4.4% | -25.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -3.5% |
-4.4% |
-25.1% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses